Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro activity of non-antibiotic drugs against Staphylococcus aureus clinical strains

21 Sept 2021

Abstract excerpt

OBJECTIVES: We hypothesised that one or more of the non-antibiotic candidates selected for this study would demonstrate antibiotic activity against Staphylococcus aureus. METHODS: We determined minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) for non-antibiotic drugs (amlodipine, azelastine, ebselen and sertraline) against five clinical S. aureus isolates and one quality...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial agents and applications
Share to Antimicrobial Resistance in Staphylococcus

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34560306
DOI: 10.1016/j.jgar.2021.09.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro activity of non-antibiotic drugs against Staphylococcus aureus clinical strainsPMID 34560306Read ↗

Oritavancin in vitro activity against contemporary Staphylococcus aureus isolates responsible for invasive community- and healthcare-associated infections among patients in the United States (2013–2014)Semantic proximity Read ↗

In vitro profiling of antimethicillin-resistant Staphylococcus aureus activity of thymoquinone against selected type and clinical strainsSemantic proximity Read ↗

The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.Semantic proximity Read ↗

A review of in-vitro antibacterial activity of quinupristin/dalfopristin against methicillin-susceptible and -resistant Staphylococcus aureus.Semantic proximity Read ↗

Anti-staphylococcal activity and mode of action of clofazimine.Semantic proximity Read ↗

Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus.Semantic proximity Read ↗

The Effects of Antidepressants Fluoxetine, Sertraline, and Amitriptyline on the Development of Antibiotic Resistance in Acinetobacter BaumanniiSemantic proximity Read ↗

In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey.Semantic proximity Read ↗

Bactericidal Activity and Resistance Development Profiling of DalbavancinSemantic proximity Read ↗

Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infection.Semantic proximity Read ↗

Comparativein vitroactivity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococciSemantic proximity Read ↗

Staphylococcus aureus mutants selected by BMS-284756.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.